Publications by authors named "Ruth Goodall"

Claim this Profile
L
Long-term non-progression in children with HIV: estimates from international cohort data.
Charlotte Jackson, Siobhan Crichton, Ali Judd, Alasdair Bamford, Philip Goulder, Ruth Goodall

AIDS· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment outcomes in people with diabetes and multidrug-resistant tuberculosis (MDR TB) enrolled in the STREAM clinical trial.
Meera Gurumurthy, Narendran Gopalan, Leena Patel, Andrew Davis, Vignes Anand Srinivasalu, Ruth Goodall

PLOS Glob Public Health· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term efficacy and safety of two short standardised regimens for the treatment of rifampicin-resistant tuberculosis (STREAM stage 2): extended follow-up of an open-label, multicentre, randomised, non-inferiority trial.
Ruth L Goodall, Andrew J Nunn, Sarah K Meredith, Adamu Bayissa, Anuj K Bhatnagar

Lancet Respir Med· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative Efficacy and Safety of Moxifloxacin and Levofloxacin in a Short Standardised Rifampicin Resistant TB Regimen: A STREAM 2 Secondary Analysis.
Stella M Fabiane, Chen-Yuan Chiang, Sarah K Meredith, Meera Gurumurthy, Adamu Bayissa, Ruth L Goodall

Trop Med Infect Dis· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
T-wave morphology abnormalities in the STREAM stage 1 trial.
Gareth Hughes, William J Young, Henry Bern, Angela Crook, Pier D Lambiase, Ruth L Goodall

Expert Opin Drug Saf· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiographic characteristics of rifampicin-resistant tuberculosis in the STREAM stage 1 trial and their influence on time to culture conversion in the short regimen.
Chen-Yuan Chiang, Henry Bern, Ruth Goodall, Shun-Tien Chien, I D Rusen

BMC Infect Dis· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of two short standardised regimens for the treatment of rifampicin-resistant tuberculosis (STREAM stage 2): an open-label, multicentre, randomised, non-inferiority trial.
Ruth L Goodall, Sarah K Meredith, Andrew J Nunn, Adamu Bayissa, Anuj K Bhatnagar

Lancet· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rethinking intercurrent events in defining estimands for tuberculosis trials.
Tra My Pham, Conor D Tweed, James R Carpenter, Brennan C Kahan, Andrew J Nunn, Ruth Goodall

Clin Trials· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Keeping up with the guidelines: design changes to the STREAM stage 2 randomised controlled non-inferiority trial for rifampicin-resistant tuberculosis.
Ruth L Goodall, Karen Sanders, Gay Bronson, Meera Gurumurthy, Gabriela Torrea

Trials· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Growth and CD4 patterns of adolescents living with perinatally acquired HIV worldwide, a CIPHER cohort collaboration analysis.

J Int AIDS Soc· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Children living with HIV in Europe: do migrants have worse treatment outcomes?
Elizabeth Chappell, Malte Kohns Vasconcelos, Ruth L Goodall, Luisa Galli, Tessa Goetghebuer

HIV Med· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The epidemiology of adolescents living with perinatally acquired HIV: A cross-region global cohort analysis.

PLoS Med· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term trends in mortality and AIDS-defining events after combination ART initiation among children and adolescents with perinatal HIV infection in 17 middle- and high-income countries in Europe and Thailand: A cohort study.

PLoS Med· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High HIV prevalence and incidence among women in Southern Mozambique: Evidence from the MDP microbicide feasibility study.
Sibone Mocumbi, Mitzy Gafos, Khatia Munguambe, Ruth Goodall, Sheena McCormack

PLoS One· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapid accumulation of HIV-1 thymidine analogue mutations and phenotypic impact following prolonged viral failure on zidovudine-based first-line ART in sub-Saharan Africa.
Ruth L Goodall, David T Dunn, Peter Nkurunziza, Lincoln Mugarura, Theresa Pattery

J Antimicrob Chemother· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The virological durability of first-line ART among HIV-positive adult patients in resource limited settings without virological monitoring: a retrospective analysis of DART trial data.
David I Dolling, Ruth L Goodall, Michael Chirara, James Hakim, Peter Nkurunziza

BMC Infect Dis· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Evidence for Reduced Drug Susceptibility without Emergence of Major Protease Mutations following Protease Inhibitor Monotherapy Failure in the SARA Trial.
Katherine A Sutherland, Chris M Parry, Adele McCormick, Anne Kapaata, Fred Lyagoba, Ruth Goodall

PLoS One· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evidence for Reduced Drug Susceptibility without Emergence of Major Protease Mutations following Protease Inhibitor Monotherapy Failure in the SARA Trial.
Katherine A Sutherland, Chris M Parry, Adele McCormick, Anne Kapaata, Fred Lyagoba, Ruth Goodall

PLoS One· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High level of viral suppression and low switch rate to second-line antiretroviral therapy among HIV-infected adult patients followed over five years: retrospective analysis of the DART trial.
Cissy Kityo, Diana M Gibb, Charles F Gilks, Ruth L Goodall, Ivan Mambule

PLoS One· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence, incidence, and associated risk factors of tuberculosis in children with HIV living in the UK and Ireland (CHIPS): a cohort study.
Anna Turkova, Elizabeth Chappell, Ali Judd, Ruth L Goodall, Steven B Welch

Lancet HIV· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gag-Protease Sequence Evolution Following Protease Inhibitor Monotherapy Treatment Failure in HIV-1 Viruses Circulating in East Africa.
Katherine A Sutherland, Ruth L Goodall, Adele McCormick, Anne Kapaata, Fred Lyagoba

AIDS Res Hum Retroviruses· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intrapatient Evolutionary Dynamics of Human Immunodeficiency Virus Type 1 in Individuals Undergoing Alternative Treatment Strategies with Reverse Transcriptase Inhibitors.
Jonathan K Kayondo, Nicaise Ndembi, Chris M Parry, Patricia A Cane, Stephane Hué, Ruth Goodall

AIDS Res Hum Retroviruses· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes after viral load rebound on first-line antiretroviraltreatment in children with HIV in the UK and Ireland: an observational cohort study.
Tristan Childs, Delane Shingadia, Ruth Goodall, Katja Doerholt, Hermione Lyall

Lancet HIV· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High rate of HIV resuppression after viral failure on first-line antiretroviral therapy in the absence of switch to second-line therapy.
Ravindra K Gupta, Ruth L Goodall, Michael Ranopa, Cissy Kityo, Paula Munderi

Clin Infect Dis· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A single CD4 test with 250 cells/mm3 threshold predicts viral suppression in HIV-infected adults failing first-line therapy by clinical criteria.
Charles F Gilks, A Sarah Walker, Paula Munderi, Cissy Kityo, Andrew Reid, Ruth L Goodall

PLoS One· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis